KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenet Healthcare (THC) Cash & Equivalents: 2009-2025

Historic Cash & Equivalents for Tenet Healthcare (THC) over the last 17 years, with Q3 2025 value amounting to $3.0 billion.

  • Tenet Healthcare's Cash & Equivalents fell 2733.27% to $3.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 billion, marking a year-over-year decrease of 2733.27%. This contributed to the annual value of $3.0 billion for FY2024, which is 14584.69% up from last year.
  • Per Tenet Healthcare's latest filing, its Cash & Equivalents stood at $3.0 billion for Q3 2025, which was down 2733.27% from $2.6 billion recorded in Q2 2025.
  • In the past 5 years, Tenet Healthcare's Cash & Equivalents registered a high of $4.1 billion during Q3 2024, and its lowest value of $766.0 million during Q1 2023.
  • Moreover, its 5-year median value for Cash & Equivalents was $2.2 billion (2021), whereas its average is $2.0 billion.
  • As far as peak fluctuations go, Tenet Healthcare's Cash & Equivalents plummeted by 6370.56% in 2022, and later soared by 28842.5% in 2024.
  • Tenet Healthcare's Cash & Equivalents (Quarter) stood at $2.4 billion in 2021, then plummeted by 63.71% to $858.0 million in 2022, then skyrocketed by 43.12% to $1.2 billion in 2023, then soared by 145.85% to $3.0 billion in 2024, then fell by 1.46% to $3.0 billion in 2025.
  • Its Cash & Equivalents stands at $3.0 billion for Q3 2025, versus $2.6 billion for Q2 2025 and $3.0 billion for Q1 2025.